This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Wake Forest University. Active years: 2000-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2006
Title: **Innovative Contributions of Robert H Mach in Cancer Research**
Introduction
Robert H Mach, an accomplished inventor based in Winston-Salem, NC, has made significant strides in the field of cancer research through his innovations. With a total of four patents to his name, his work focuses on understanding and diagnosing cancers at a molecular level. Mach's inventive spirit is evidenced by his latest patents, which hold promise for advancements in cancer imaging and treatment.
Latest Patents
Mach's recent patents highlight his commitment to developing diagnostic methods and therapeutic compositions. The first patent, titled "Methods and compositions utilizing an alternative splice variant of the sigma-1 receptor," introduces a new variant of the sigma-1 receptor, which is instrumental in creating non-invasive imaging techniques for tumors. This variant, called sigma-1, plays a crucial role in identifying proliferative cancer cells, thereby facilitating early diagnosis and potentially improving treatment outcomes.
Another notable patent, "Sigma-2 receptors as biomarkers of tumor cell proliferation," involves detectably-labeled compounds that are useful in competitive assays to identify the presence of sigma-2 receptors. This patent details compounds of specific formulas and their pharmaceutical compositions, offering innovative methods for the detection and analysis of cancer cell proliferation.
Career Highlights
Mach is associated with Wake Forest University, where his research focuses on understanding complex biological processes related to cancer. His work not only contributes to the academic community but also provides practical solutions that can enhance diagnostic and therapeutic measures in oncology.
Collaborations
Collaboration has played a vital role in Mach's career. He has worked alongside esteemed colleagues Kenneth T Wheeler and Steven R Childers, contributing to a collaborative environment that fosters innovation and research excellence. Through these partnerships, they have advanced the science of cancer detection and treatment, leading to potentially life-saving applications.
Conclusion
Robert H Mach's contributions to cancer research underscore the importance of innovation in the medical field. With his recent patents focusing on sigma receptors, he is paving the way for more accurate diagnostics and treatment options for cancer patients. His dedication to research and collaboration highlights the significant impact inventors like him can have on public health and medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
